Welcome to our dedicated page for Atomera news (Ticker: ATOM), a resource for investors and traders seeking the latest updates and insights on Atomera stock.
Atomera Incorporated (NASDAQ: ATOM) is a semiconductor materials and technology licensing company whose news flow centers on the development and commercialization of its Mears Silicon Technology™ (MST®). As a Nasdaq-listed issuer, Atomera regularly publishes updates on its technology progress, customer collaborations and financial performance, providing investors and industry observers with insight into how its MST process is being evaluated and adopted across the semiconductor ecosystem.
News about Atomera often includes quarterly financial results, typically accompanied by live video webinars where management discusses recent progress, customer wafer activity and the status of joint development and licensing engagements. These releases are frequently followed by Form 8-K filings that furnish the related press releases and investor presentations. Such updates give context on Atomera’s operating expenses, cash position and the pace of its early-stage commercialization efforts.
Beyond earnings, Atomera issues technology and partnership announcements. Recent examples include a strategic marketing agreement with a global chip fabrication equipment vendor to align MST with that vendor’s tools, and a collaboration with Incize to explore MST in GaN-on-Si platforms for next-generation RF and power devices. The company also highlights research it has commissioned on AI and high-performance computing workloads, emphasizing the role of advanced materials like MST in achieving performance and energy-efficiency gains.
Visitors to this ATOM news page can review Atomera’s press releases on collaborations, participation in initiatives such as the National Semiconductor Technology Center, leadership appointments and other corporate developments. For those tracking how advanced materials and process IP are being integrated into mainstream semiconductor manufacturing, Atomera’s news provides an ongoing view of its activities, partnerships and strategic direction.
Atomera (NASDAQ:ATOM), a semiconductor materials and technology licensing company, reported its Q1 2025 financial results. The company recorded a net loss of $5.2 million ($0.17 per share), compared to a loss of $4.8 million ($0.19 per share) in Q1 2024. Cash position stood at $24.1 million as of March 31, 2025, down from $26.8 million at the end of 2024.
Key developments include signing a strategic marketing agreement with a leading chip fabrication equipment vendor, expanding engagements with ST Microelectronics and RFSOI customers, and building first-ever MST-enabled GaN devices at Sandia. The company believes its new equipment vendor collaboration will drive license revenues while benefiting both parties.
Summary not available.
Atomera (NASDAQ:ATOM), a semiconductor materials and technology licensing company, has scheduled its first quarter 2025 financial results announcement for Tuesday, May 6, 2025, after market close. The company will hold a live video Zoom webinar at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day to discuss the quarterly results. Investors can access the webinar through Atomera's investor relations website, with a replay available for 12 months.
Atomera (NASDAQ:ATOM) has released its Q4 and fiscal 2024 financial results, highlighting continued progress in commercialization efforts with ST Microelectronics and expanded offerings for gate-all-around products for AI devices. The company reported new development initiatives with two large customers.
Financial highlights for Q4 2024 include a net loss of $4.7 million ($0.16 per share), compared to Q3 2024's loss of $4.6 million ($0.17 per share). For fiscal year 2024, revenue was $135,000, down from $550,000 in 2023, with a net loss of $18.4 million ($0.68 per share) compared to $19.8 million ($0.80 per share) in 2023.
The company's cash position strengthened to $26.8 million as of December 31, 2024, up from $19.5 million year-over-year, with 30.1 million total shares outstanding.
Atomera (NASDAQ:ATOM), a semiconductor materials and technology licensing company, has scheduled its fourth quarter and fiscal year 2024 financial results announcement for Tuesday, February 11, 2025, after market close. The company will host a live video Zoom webinar at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day to discuss the results. Investors can access the webinar through Atomera's investor relations website, and a replay will be available for 12 months.
Atomera (NASDAQ:ATOM), a semiconductor materials and licensing company, has announced its upcoming virtual presentation at the 27th Annual Needham Growth Conference on Thursday, January 16, 2025. The presentation will begin at 11:45 a.m. Eastern Time and will be accessible through a live webcast on Atomera's investor relations website at ir.atomera.com.
The webcast recording will remain available for 90 days following the presentation. Additionally, the company has scheduled one-on-one meetings with institutional analysts and investors throughout the conference day.
Atomera (NASDAQ:ATOM), a semiconductor materials and technology licensing company, reported Q3 2024 financial results. The company announced a net loss of $4.6 million ($0.17 per share), compared to a $5.0 million loss ($0.20 per share) in Q3 2023. Cash and equivalents stood at $17.3 million as of September 30, 2024, down from $19.5 million at the end of 2023. The company highlighted a new collaboration with Sandia National Laboratories' CINT to validate MST's capabilities in GaN manufacturing. Total shares outstanding were 28.3 million as of September 30, 2024.
Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, has announced it will release its third quarter 2024 financial results after market close on Tuesday, October 29, 2024. The company will host a live video Zoom webinar at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day to discuss the results.
Investors can access the live webinar through Atomera's investor relations website at https://ir.atomera.com. A replay of the webcast will be available for 12 months. Atomera's proprietary Mears Silicon Technology™ (MST®) aims to increase performance and power efficiency in semiconductor transistors, and can be implemented using existing equipment in semiconductor manufacturing facilities.
Atomera Incorporated (NASDAQ: ATOM) has announced a collaboration with the Center for Integrated Nanotechnologies (CINT) at Sandia National Laboratories to address challenges in growing Gallium Nitride (GaN) films on Silicon (Si). The project aims to create the first GaN transistors using Atomera's Mears Silicon Technology™ (MST®).
The collaboration will utilize CINT's advanced facilities to quickly evaluate the effectiveness of GaN transistors with MST. The project builds on improvements observed in GaN/MST on Silicon wafers at the materials level. MST has the potential to improve GaN on Si manufacturing, offering benefits in speed, efficiency, and cost-saving for various industries including electronics, RF/microwave electronics, and MicroLEDs.
The project aims to validate the mechanical and electrical benefits of MST-enhanced GaN on Si, addressing manufacturing limitations that have hindered the widespread adoption of GaN for modern power electronics. MST's ability to relieve biaxial tensile stress could potentially improve the growth of GaN epitaxy on Si substrates, overcoming current limitations in commercially available GaN on Si power electronics devices.
Atomera (NASDAQ:ATOM), a semiconductor materials and technology licensing company, reported its Q2 2024 financial results. Key highlights include:
- Announced availability of MST® RFSOI wafer substrates for cellular communication products
- Added new VP of Marketing and Business Development
- Submitted first proposal under the Chips and Sciences Act
- Net loss of ($4.4) million, or ($0.16) per share, compared to ($5.2) million, or ($0.21) per share in Q2 2023
- Adjusted EBITDA loss of ($3.6) million, improved from ($4.3) million in Q2 2023
- Cash, cash equivalents, and short-term investments of $18.3 million as of June 30, 2024
- 27.6 million total shares outstanding as of June 30, 2024
The company reports progress in technology development and commercial proposals, with expectations to convert opportunities into license revenue.